Sanofi Stops Supplying Hydroxychloroquine to COVID-19 Patients in Clinical Trials
The malaria drug is quickly falling out of favor with the medical community as a potential treatment for the disease.
Full Article
Sanofi Stops Supplying Hydroxychloroquine to COVID-19 Patients in Clinical Trials
Motley Fool
0 shares
1 views
You might like
Related news coverage
Scientists raise concern over hydroxychloroquine study
WorldNews
Dozens of scientists have raised concerns over a large-scale study of hydroxychloroquine and chloroquine that led to the World..
Advertisement
More coverage
Meet the 26 healthcare startups that top VCs say are poised to take off amid the coronavirus pandemic
Business Insider
· Business Insider asked 13 top venture capital investors which startups they think will thrive despite the coronavirus pandemic,..
